Fetopathy associated with exposure to angiotensin converting enzyme inhibitors.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/685 |
Resumo: | Angiotensin Converting Enzyme Inhibitors (ACEI) are commonly used antihypertensive drugs, although contraindicated during pregnancy by fetopathy association such as renal dysgenesis, oligohydramnios, hipocalvaria, pulmonary hypoplasia, intrauterine growth restriction, and neonatal anuric renal failure. The authors present a clinical report of a child that developed neonatal anuric renal failure with peritoneal dialysis support by an in uterus exposure to ACEI with very good recovery. This case and literature review states the need to avoid ACEI prescription to Young women and it's suspension as soon as possible during pregnancy. |
id |
RCAP_3a453ee346f71fed137fa6567f461136 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/685 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors.Fetopatia pelo uso de inibidores da enzima de conversão da angiotensina.Angiotensin Converting Enzyme Inhibitors (ACEI) are commonly used antihypertensive drugs, although contraindicated during pregnancy by fetopathy association such as renal dysgenesis, oligohydramnios, hipocalvaria, pulmonary hypoplasia, intrauterine growth restriction, and neonatal anuric renal failure. The authors present a clinical report of a child that developed neonatal anuric renal failure with peritoneal dialysis support by an in uterus exposure to ACEI with very good recovery. This case and literature review states the need to avoid ACEI prescription to Young women and it's suspension as soon as possible during pregnancy.Angiotensin Converting Enzyme Inhibitors (ACEI) are commonly used antihypertensive drugs, although contraindicated during pregnancy by fetopathy association such as renal dysgenesis, oligohydramnios, hipocalvaria, pulmonary hypoplasia, intrauterine growth restriction, and neonatal anuric renal failure. The authors present a clinical report of a child that developed neonatal anuric renal failure with peritoneal dialysis support by an in uterus exposure to ACEI with very good recovery. This case and literature review states the need to avoid ACEI prescription to Young women and it's suspension as soon as possible during pregnancy.Ordem dos Médicos2010-07-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/685oai:ojs.www.actamedicaportuguesa.com:article/685Acta Médica Portuguesa; Vol. 23 No. 4 (2010): July-August; 697-700Acta Médica Portuguesa; Vol. 23 N.º 4 (2010): Julho-Agosto; 697-7001646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/685https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/685/363Neves, SérgioSantos, RaquelGomes, ClaraCorreia, António Jorgeinfo:eu-repo/semantics/openAccess2022-12-20T10:56:42Zoai:ojs.www.actamedicaportuguesa.com:article/685Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:16:40.848676Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors. Fetopatia pelo uso de inibidores da enzima de conversão da angiotensina. |
title |
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors. |
spellingShingle |
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors. Neves, Sérgio |
title_short |
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors. |
title_full |
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors. |
title_fullStr |
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors. |
title_full_unstemmed |
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors. |
title_sort |
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors. |
author |
Neves, Sérgio |
author_facet |
Neves, Sérgio Santos, Raquel Gomes, Clara Correia, António Jorge |
author_role |
author |
author2 |
Santos, Raquel Gomes, Clara Correia, António Jorge |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Neves, Sérgio Santos, Raquel Gomes, Clara Correia, António Jorge |
description |
Angiotensin Converting Enzyme Inhibitors (ACEI) are commonly used antihypertensive drugs, although contraindicated during pregnancy by fetopathy association such as renal dysgenesis, oligohydramnios, hipocalvaria, pulmonary hypoplasia, intrauterine growth restriction, and neonatal anuric renal failure. The authors present a clinical report of a child that developed neonatal anuric renal failure with peritoneal dialysis support by an in uterus exposure to ACEI with very good recovery. This case and literature review states the need to avoid ACEI prescription to Young women and it's suspension as soon as possible during pregnancy. |
publishDate |
2010 |
dc.date.none.fl_str_mv |
2010-07-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/685 oai:ojs.www.actamedicaportuguesa.com:article/685 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/685 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/685 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/685 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/685/363 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 23 No. 4 (2010): July-August; 697-700 Acta Médica Portuguesa; Vol. 23 N.º 4 (2010): Julho-Agosto; 697-700 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130620728705024 |